AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India flag India · Delayed Price · Currency is INR
7,942.00
-148.00 (-1.83%)
Aug 11, 2026, 3:30 PM IST

AstraZeneca Pharma India Statistics

Total Valuation

NSE:ASTRAZEN has a market cap or net worth of INR 201.93 billion. The enterprise value is 198.56 billion.

Market Cap201.93B
Enterprise Value 198.56B

Important Dates

The last earnings date was Monday, August 10, 2026.

Earnings Date Aug 10, 2026
Ex-Dividend Date Jul 31, 2026

Share Statistics

Current Share Class 25.00M
Shares Outstanding n/a
Shares Change (YoY) -0.02%
Shares Change (QoQ) +0.00%
Owned by Insiders (%) 6.18%
Owned by Institutions (%) 8.23%
Float 4.61M

Valuation Ratios

The trailing PE ratio is 119.05.

PE Ratio 119.05
Forward PE n/a
PS Ratio 8.31
PB Ratio 23.14
P/TBV Ratio 23.14
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 117.06
EV / Sales 8.17
EV / EBITDA 88.79
EV / EBIT 94.15
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.13
Debt / EBITDA 0.49
Debt / FCF -6.63
Interest Coverage 36.87

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 29.26%
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) 5.59%
Revenue Per Employee 31.97M
Profits Per Employee 2.23M
Employee Count760
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, NSE:ASTRAZEN has paid 586.30 million in taxes.

Income Tax 586.30M
Effective Tax Rate 25.69%

Stock Price Statistics

The stock price has decreased by -9.59% in the last 52 weeks. The beta is 0.25, so NSE:ASTRAZEN's price volatility has been lower than the market average.

Beta (5Y) 0.25
52-Week Price Change -9.59%
50-Day Moving Average 8,250.06
200-Day Moving Average 8,601.17
Relative Strength Index (RSI) 41.89
Average Volume (20 Days) 14,700

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NSE:ASTRAZEN had revenue of INR 24.30 billion and earned 1.70 billion in profits. Earnings per share was 67.85.

Revenue24.30B
Gross Profit 8.94B
Operating Income 2.11B
Pretax Income 2.28B
Net Income 1.70B
EBITDA 2.24B
EBIT 2.11B
Earnings Per Share (EPS) 67.85
Full Income Statement

Balance Sheet

The company has 4.48 billion in cash and 1.11 billion in debt, with a net cash position of 3.37 billion.

Cash & Cash Equivalents 4.48B
Total Debt 1.11B
Net Cash 3.37B
Net Cash Per Share n/a
Equity (Book Value) 8.73B
Book Value Per Share 349.12
Working Capital n/a
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -151.40 million and capital expenditures -15.60 million, giving a free cash flow of -167.00 million.

Operating Cash Flow -151.40M
Capital Expenditures -15.60M
Depreciation & Amortization 127.43M
Net Borrowing -74.80M
Free Cash Flow -167.00M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 36.77%, with operating and profit margins of 8.68% and 6.98%.

Gross Margin 36.77%
Operating Margin 8.68%
Pretax Margin 9.39%
Profit Margin 6.98%
EBITDA Margin 9.20%
EBIT Margin 8.68%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 36.00, which amounts to a dividend yield of 0.45%.

Dividend Per Share 36.00
Dividend Yield 0.45%
Dividend Growth (YoY) 12.50%
Years of Dividend Growth 4
Payout Ratio 53.06%
Buyback Yield 0.02%
Shareholder Yield 0.46%
Earnings Yield 0.84%
FCF Yield -0.08%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1